SCN5A Variant P119S
Summary of observed carriers, functional annotations, and structural context for SCN5A P119S. Data combine curated literature, international cohorts, and gnomAD observations.
Estimated LQT3 penetrance
6%
0/12 effective observations
Estimated BrS1 penetrance
11%
1/12 effective observations
Total carriers
2
0 BrS1 · 0 LQT3 · 2 unaffected
Variant features alone are equivalent to phenotyping 1 individuals for Brugada syndrome and 0 individuals for LQT3.
In silico predictors
PROVEAN | PolyPhen-2 | BLAST-PSSM | REVEL | Penetrance Density BrS (%) | Penetrance Density LQT3 (%) |
---|---|---|---|---|---|
-4.18 | 0.961 | -0.5 | 0.714 | 11 | 4 |
PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).
Reported carrier data
Source | Year | Carriers | Unaffected | LQT3 | BrS1 | Other | Other Disease |
---|---|---|---|---|---|---|---|
Literature, cohort, and gnomAD | – | 2 | 2 | 0 | 0 | – | |
Variant features alone | – | 15 | 14 | 0 | 1 | – | – |
Totals may differ from individual publications due to duplicate patients removed during curation.
Nearby variants
Neighbouring residues within 15 Ångström provide structural context. Variants listed in the right-most column have been observed clinically or in gnomAD.
Neighbour residue | Distance (Å) | Observed variants |
---|---|---|
126 | 10 | K126E, |
178 | 12 | A178G, |
117 | 8 | |
119 | 0 | P119L, P119S, |
179 | 14 | R179Q, R179X, |
177 | 11 | L177P, |
123 | 7 | A123V, A123G, |
121 | 7 | R121W, R121Q, |
127 | 13 | |
124 | 9 | A124D, |
118 | 5 | |
125 | 10 | V125L, |
174 | 14 | V174I, |
115 | 9 | S115G, |
112 | 15 | Y112C, |
114 | 12 | |
116 | 9 | |
180 | 15 | G180V, |
120 | 4 | |
122 | 5 |